Boston, MA 09/02/2014 (wallstreetpr) – Primary endpoints results of the clinical trial of Neural Cardiac Therapy for Heart Failure (NECTAR-HF) were released by Boston Scientific
Boston, MA 08/25/2014 (wallstreetpr) – In order to put the acquisition of Allergan, Inc. (NYSE:AGN) deal in the fastest gear, Valeant Pharmaceuticals Intl Inc (NYSE:VRX) as
Boston, MA 05/19/2014 (wallstreetpr) – On Friday, Republic First Bancorp, Inc.(NASDAQ:FRBK) located in Philadelphia announced that it has concluded the private placement of$45 million of
Boston, MA 05/07/2014 (wallstreetpr) – Casino entertainment provider, Caesars Entertainment Corp (NASDAQ:CZR), is up in intraday trading session by a high of 14.71% after the company
Boston, MA 05/05/2014 (wallstreetpr) – PBF Energy Inc (NYSE:PBF) wants to see growth. The company has already made internal improvements to curb costs and expenses while
Dallas, Texas 04/29/2014 (ustradevoice) – After being refused earlier for takeover negotiations, Allergan, Inc. (NYSE:AGN) decides to go forward for a more serious takeover talks with
Boston, MA 09/02/2014 (wallstreetpr) – Primary endpoints results of the clinical trial of Neural Cardiac Therapy for Heart Failure (NECTAR-HF) were released by Boston Scientific
Boston, MA 08/25/2014 (wallstreetpr) – In order to put the acquisition of Allergan, Inc. (NYSE:AGN) deal in the fastest gear, Valeant Pharmaceuticals Intl Inc (NYSE:VRX) as
Boston, MA 05/19/2014 (wallstreetpr) – On Friday, Republic First Bancorp, Inc.(NASDAQ:FRBK) located in Philadelphia announced that it has concluded the private placement of$45 million of
Boston, MA 05/07/2014 (wallstreetpr) – Casino entertainment provider, Caesars Entertainment Corp (NASDAQ:CZR), is up in intraday trading session by a high of 14.71% after the company
Boston, MA 05/05/2014 (wallstreetpr) – PBF Energy Inc (NYSE:PBF) wants to see growth. The company has already made internal improvements to curb costs and expenses while
Dallas, Texas 04/29/2014 (ustradevoice) – After being refused earlier for takeover negotiations, Allergan, Inc. (NYSE:AGN) decides to go forward for a more serious takeover talks with
